Melissa Baird, Chief Operating Officer at Hims & Hers Health, Inc. (HIMS), sold 171,122 shares at $31.98 ($5.3M) on 2024-12-10, disclosed to the SEC on 2024-12-12.
Scheduled sale ($5.3M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.55 | 26,266 | $802K | 15.1% |
| 2 | $30.55 | 26,266 | $802K | 15.1% |
| 3 | $31.09 | 51,082 | $1.6M | 29.9% |
| 4 | $31.09 | 51,082 | $1.6M | 29.9% |
| 5 | $31.98 | 8,213 | $263K | 4.9% |
| 6 | $31.98 | 8,213 |
| $263K |
| 4.9% |
| Total | $31.01 avg | 171,122 | $5.3M | 100% |
| Filing → |
| HIMS | SELL | 2025-04-10 | $1.8M | — | Filing → |
| HIMS | SELL | 2025-03-27 | $4.7M | — | Filing → |
| HIMS | SELL | 2025-02-14 | $6.1M | — | Filing → |